Clinical Trial Update: Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073

View source ↗

Summary

A real-world effectiveness study in France evaluating bictegravir/emtricitabine/tenofovir alafenamide for people living with HIV in precarious settings; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) (bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | Conditions: HIV-1, Public Universal Healthcare Insurance Coverage | Status: NOT_YET_RECRUITING